List of Tables
Table 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Intratumoral
Table 4. Key Players of Intraperitoneal
Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Therapy for Ovarian Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2016-2021)
Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2022-2027)
Table 11. Gene Therapy for Ovarian Cancer Market Trends
Table 12. Gene Therapy for Ovarian Cancer Market Drivers
Table 13. Gene Therapy for Ovarian Cancer Market Challenges
Table 14. Gene Therapy for Ovarian Cancer Market Restraints
Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gene Therapy for Ovarian Cancer Market Share by Players (2016-2021)
Table 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2020)
Table 18. Ranking of Global Top Gene Therapy for Ovarian Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
Table 22. Date of Enter into Gene Therapy for Ovarian Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takara Bio Company Details
Table 63. Takara Bio Business Overview
Table 64. Takara Bio Gene Therapy for Ovarian Cancer Product
Table 65. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 66. Takara Bio Recent Development
Table 67. VBL Therapeutics Company Details
Table 68. VBL Therapeutics Business Overview
Table 69. VBL Therapeutics Gene Therapy for Ovarian Cancer Product
Table 70. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 71. VBL Therapeutics Recent Development
Table 72. CELSION Company Details
Table 73. CELSION Business Overview
Table 74. CELSION Gene Therapy for Ovarian Cancer Product
Table 75. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 76. CELSION Recent Development
Table 77. Targovax Company Details
Table 78. Targovax Business Overview
Table 79. Targovax Gene Therapy for Ovarian Cancer Product
Table 80. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2016-2021) & (US$ Million)
Table 81. Targovax Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Intratumoral Features
Figure 4. Intraperitoneal Features
Figure 5. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2020 VS 2027
Figure 6. Ovarian Cancer (Unspecified) Case Studies
Figure 7. Recurrent Ovarian Epithelial Cancer Case Studies
Figure 8. Platinum-Resistant Ovarian Cancer Case Studies
Figure 9. Gene Therapy for Ovarian Cancer Report Years Considered
Figure 10. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gene Therapy for Ovarian Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2022-2027)
Figure 14. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2020
Figure 15. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2020
Figure 17. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 21. North America Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 22. North America Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 23. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 27. Europe Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 28. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 29. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Region (2016-2027)
Figure 39. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gene Therapy for Ovarian Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 59. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 60. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 61. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed